GlassScriptPhysician profile
Peter J Shekailo
NPI 1477967768
$7,333.39
in general payments reported to CMS, 2019-2025
20 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $5,583 · 2021: $860 · 2022: $152 · 2023: $61.33 · 2024: $16.60 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,359.51 | 2020-2023 | Pico 14 |
| Encore Medical, LP | $1,589.39 | 2019-2021 | |
| Stryker Corporation | $597.00 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $188.39 | 2025 | Mymobility Platform, Rosa |
| Depuy Synthes Sales INC. | $143.44 | 2020-2022 | |
| Integra Lifesciences Corporation | $134.68 | 2019 | |
| Pacira Therapeutics, INC. | $51.98 | 2020-2021 | |
| Davol INC. | $44.24 | 2023-2025 | Arista |
| Pacira Pharmaceuticals Incorporated | $35.18 | 2023-2024 | Iovera, Zilretta, Exparel |
| Biocomposites INC | $30.73 | 2022 | |
| Innovation Technologies INC | $24.66 | 2022 | |
| Sanara Medtech INC. | $23.81 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.46 | 2025 | |
| Guard Medical INC. | $16.32 | 2025 | Npseal |
| Fidia Pharma USA INC. | $15.96 | 2025 | Hymovis, Triluron |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragen, INC. | $15.36 | 2022 | |
| Ethicon US, LLC | $14.78 | 2020 | |
| Heraeus Medical, LLC. | $12.74 | 2025 | |
| Ibsa Pharma INC. | $11.08 | 2021 | |
| Embody, INC. | $2.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shekailo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.